Vanda Announces Positive Phase II Study Results for Tradipitant

VNDA: Vanda Pharmaceuticals Inc.
2018-12-03 06:00:00
Vanda Announces Positive Phase II Study Results for Tradipitant in Patients with Gastroparesis